John Kilgore, MD
Adult Reconstructive Orthopaedic Surgery · Clearwater, FLNPI 1770526410
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $96,000 of the $110,989 with a category attached, or 86.5%. Stryker accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $44,427 and has fallen 99.7% since, to $119 in 2025.
Across 148 payments — averaging $749.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$111K
- Amgen$209
- Johnson & Johnson$65
- Molnlycke Health Care US, LLC$38
- Theragen, Inc.$23
- Pacira Therapeutics, Inc.$18
What the payments were for
- Consulting fees$96,00086%
- Travel & lodging$12,26711%
- Food & beverage$2,7232%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 140 | $110,637 |
| Amgen | 2 | $209 |
| Johnson & Johnson | 2 | $65 |
| Molnlycke Health Care US, LLC | 2 | $38 |
| Theragen, Inc. | 1 | $23 |
| Pacira Therapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$110,989 in reported general payments places this provider in the 85th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 179 | $8,522 |
| Meloxicam | 53 | $226 |
| Tizanidine Hcl | 21 | $129 |
| Mupirocin | 25 | $129 |
| Amoxicillin | 50 | $101 |
| Methylprednisolone | 15 | $80 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Clearwater
- David WhiddonClearwater$8K
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.